Carolin Fremer

931 total citations
21 papers, 283 citations indexed

About

Carolin Fremer is a scholar working on Clinical Psychology, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Carolin Fremer has authored 21 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Clinical Psychology, 10 papers in Pharmacology and 3 papers in Experimental and Cognitive Psychology. Recurrent topics in Carolin Fremer's work include Obsessive-Compulsive Spectrum Disorders (19 papers), Eating Disorders and Behaviors (10 papers) and Cannabis and Cannabinoid Research (10 papers). Carolin Fremer is often cited by papers focused on Obsessive-Compulsive Spectrum Disorders (19 papers), Eating Disorders and Behaviors (10 papers) and Cannabis and Cannabinoid Research (10 papers). Carolin Fremer collaborates with scholars based in Germany, Poland and Denmark. Carolin Fremer's co-authors include Kirsten Müller‐Vahl, Ewgeni Jakubovski, Natalia Szejko, Martina Haas, Christoph Schindler, Henrik Loft, Chan Beals, Bürkard Jäger, Pieter J. Hoekstra and Andrea Dietrich and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Scientific Reports.

In The Last Decade

Carolin Fremer

19 papers receiving 273 citations

Peers

Countries citing papers authored by Carolin Fremer

Since Specialization

Citations

This map shows the geographic impact of Carolin Fremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolin Fremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolin Fremer more than expected).

Fields of papers citing papers by Carolin Fremer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolin Fremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolin Fremer. The network helps show where Carolin Fremer may publish in the future.

Co-authorship network of co-authors of Carolin Fremer

This figure shows the co-authorship network connecting the top 25 collaborators of Carolin Fremer. A scholar is included among the top collaborators of Carolin Fremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolin Fremer. Carolin Fremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term use of cannabis-based medicines in two children with Tourette syndrome: a case report 2025 ·Frontiers in Psychiatry ·(unknown), Natalia Szejko, Carolin Fremer, Simon Schmitt, (unknown)	0
2	Prevalence of mass social media-induced illness presenting with Tourette-like behavior in Germany between 2019 and 2021 2024 ·Journal of Psychiatric Research ·K Hartung, (unknown), Carolin Fremer, (unknown), Martina Haas, Ewgeni Jakubovski, Natalia Szejko, Valerie Brandt, Kirsten Müller‐Vahl	2
3	The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial 2024 ·Cannabis and Cannabinoid Research ·Kirsten Müller‐Vahl, (unknown), (unknown), (unknown), Carolin Fremer, Elif Weidinger, (unknown), Richard Musil, Alexander Brunnauer, Anika Großhennig	1
4	Functional Tic‐Like Behaviors: A Common Comorbidity in Patients with Tourette Syndrome 2023 ·Movement Disorders Clinical Practice ·Kirsten Müller‐Vahl, (unknown), Carolin Fremer, Martina Haas, Ewgeni Jakubovski, Natalia Szejko	10
5	What distinguishes patients with mass social media-induced illness presenting with Tourette-like behavior from those with Tourette syndrome? Results of a prospective cohort study 2023 ·European Archives of Psychiatry and Clinical Neuroscience ·Carolin Fremer, Natalia Szejko, (unknown), Martina Haas, (unknown), Claudia Wegener, Kirsten Müller‐Vahl	7
6	Non-just-right experiences are more closely related to OCD than tics in Tourette patients 2023 ·Scientific Reports ·Valerie Brandt, (unknown), Carolin Fremer, Ewgeni Jakubovski, Kirsten Müller‐Vahl	5
7	CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders – Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study 2023 ·Psychiatry Research ·Kirsten Müller‐Vahl, (unknown), Natalia Szejko, Martina Haas, Carolin Fremer, Ewgeni Jakubovski, Richard Musil, Alexander Münchau, Irene Neuner, Daniel Huys, Ludger Tebartz van Elst, Heinz C. Schröder, (unknown), Armin Koch, (unknown), Anika Großhennig	13
8	Mass social media-induced illness presenting with Tourette-like behavior 2022 ·Frontiers in Psychiatry ·Carolin Fremer, Natalia Szejko, (unknown), Martina Haas, (unknown), Claudia Wegener, Kirsten Müller‐Vahl	11
9	CANNA-TICS: Efficacy and Safety of Oral Treatment with Nabiximols in Adults with Chronic Tic Disorders – Results of a Prospective, Multicenter, Randomized, Double-Blind, Placebo Controlled, Phase IIIb Superiority Study 2022 ·SSRN Electronic Journal ·Kirsten Müller‐Vahl, (unknown), Natalia Szejko, Martina Haas, Carolin Fremer, Ewgeni Jakubovski, Richard Musil, Alexander Münchau, Irene Neuner, Daniel Huys, Ludger Tebartz van Elst, (unknown), (unknown), Armin Koch, (unknown), Anika Großhennig	0
10	Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial 2022 ·Frontiers in Neuroscience ·Kirsten Müller‐Vahl, Ewgeni Jakubovski, Carolin Fremer, (unknown), Anika Großhennig, (unknown), Armin Koch, Martina Haas, (unknown)	5
11	Cannabis Improves Stuttering: Case Report and Interview with the Patient 2021 ·Cannabis and Cannabinoid Research ·Natalia Szejko, Carolin Fremer, (unknown), M. Ptok, Kirsten Müller‐Vahl	1
12	Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study 2021 ·Pharmacopsychiatry ·Kirsten Müller‐Vahl, Carolin Fremer, Chan Beals, (unknown), Henrik Loft, Christoph Schindler	21
13	Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study 2021 ·Frontiers in Psychiatry ·Martina Haas, Ewgeni Jakubovski, Carolin Fremer, Andrea Dietrich, Pieter J. Hoekstra, Bürkard Jäger, Kirsten Müller‐Vahl, (unknown)	37
14	Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study 2021 ·Movement Disorders ·Kirsten Müller‐Vahl, Carolin Fremer, Chan Beals, (unknown), Henrik Loft, Christoph Schindler	36
15	Stop that! It’s not Tourette’s but a new type of mass sociogenic illness 2021 ·Brain ·Kirsten Müller‐Vahl, (unknown), Ewgeni Jakubovski, Carolin Fremer	64
16	The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders 2020 ·Frontiers in Psychiatry ·Ewgeni Jakubovski, (unknown), Carolin Fremer, Martina Haas, Marcus May, (unknown), Christoph Schindler, (unknown), Lukas Aguirre Dávila, Armin Koch, Alexander Brunnauer, (unknown), Beat Lutz, Laura Bîndilă, Kirsten Müller‐Vahl	19
17	Intravenous Immunoglobulin Treatment Did Not Improve Tics in a Patient With Gilles de la Tourette Syndrome and Intrathecal Antibody Synthesis 2020 ·Frontiers in Neurology ·Natalia Szejko, Carolin Fremer, Kurt‐Wolfram Sühs, (unknown), Kirsten Müller‐Vahl	2
18	Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature 2020 ·Frontiers in Psychiatry ·Natalia Szejko, Carolin Fremer, Kirsten Müller‐Vahl	19
19	Vaporized Cannabis Is Effective and Well-Tolerated in an Adolescent with Tourette Syndrome 2019 ·SHILAP Revista de lepidopterología ·Natalia Szejko, Ewgeni Jakubovski, Carolin Fremer, Kirsten Müller‐Vahl	9
20	Delta-9-tetrahydrocannabinol for the treatment of a child with Tourette syndrome: case report 2018 ·Natalia Szejko, Ewgeni Jakubovski, Carolin Fremer, (unknown), Kirsten Müller‐Vahl	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact